Cleared Traditional

Arterys Cardio DL (K163253) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K163253 · Arterys, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2017
Decision
48d
Days
Class 2
Risk

K163253 is an FDA 510(k) clearance for the Arterys Cardio DL. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Arterys, Inc. (San Francisco, US). The FDA issued a Cleared decision on January 5, 2017 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Arterys, Inc. devices

Submission Details

510(k) Number K163253 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2016
Decision Date January 05, 2017
Days to Decision 48 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 107d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 800
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K163253.
Lung Nodule Assessment and Comparison Option (LNA)
K162484 · Philips Medical Systems Nederland B.V. · Feb 2017
syngo.MR General, syngo.MR Cardiology, syngo.MR Neurology
K163294 · Siemens Medical Solutions USA, Inc. · Feb 2017
NobelClinician, DTX Studio implant
K163122 · Nobel Biocare AB · Jan 2017
syngo.via MI Workflows
K163421 · Siemens Medical Solutions USA, Inc. · Jan 2017
syngo Application Software
K162541 · Siemens Medical Solutions USA, Inc. · Nov 2016
Scenium
K162339 · Siemens Medical Solutions USA, Inc. · Sep 2016